To arrive at a better understanding of the eects of the glucocorticoid component of chemotherap#y protocols on lymphocytic leukemia cells, we analysed early responses of T-lymphocytic leukemia cell lines Jurkat and CEM-C7, both of which undergo apoptosis in response to dexamethasone, via gene chips. Among genes identi®ed as repressed, a notable cluster seemed to be of importance for the processes of transcription, mRNA splicing and protein synthesis. Consequently, we assessed time-resolved uptake of uridine and methionine to monitor RNA and protein synthesis, along with parameters quantifying apoptosis. Repression of uptake to about 65% of that in untreated cells preceded the ®rst sign of apoptosis by several hours in both cell lines. In addition to this general repression of RNA and protein synthesis, several genes were found to be regulated that may contribute to synergistic action of glucocorticoids with other components of frequently used chemotherapy protocols such as antimetabolites, methotrexate and alkylating agents. Oncogene (2001) 20, 4324 ± 4336.
Introduction
Glucocorticoids (GC) are at the same time vital steroid hormones present in every human organism, as well as widely-used drugs. In their physiological function, GC in¯uence a wide array of tissues with the overall goal of enabling the organism to cope with stress situations. Eects concern carbohydrate, protein and fat metabolism;¯uid and electrolyte balance including kidney and cardiovascular system; endocrine, nervous and immune systems; bones, connective tissue and skeletal muscles. GC eects are often permissive, enabling target organ systems to respond more eectively to other stimuli (Schimmer and Parker, 1996) .
GC act by binding to the glucocorticoid receptor (GR), a protein that, in the absence of ligand, remains cytoplasmic by binding to a large, dynamic multiprotein complex containing heat shock protein molecules ± hsp90 or hsp90 plus hsp70 ± and an immunophilin component (Tai et al., 1992) . The immunophilin moiety binds to hsp90 via its tetratricopeptide repeat domain and may be represented by any one of several proteins, such as FKBP51, FKBP52, CyP-40 or even protein phosphatase 5 (PP5) (Owens-Grillo et al., 1995; Silverstein et al., 1997 Silverstein et al., , 1999 . Steroid binding results in a conformational change, detachment from the associated proteins and unmasking of a nuclear translocation signal. In the nucleus, the GR acts as a transcription factor capable of both transactivating and transrepressing transcription of speci®c genes, depending on the exact context of cis-acting promoter/ enhancer elements and their cognate binding proteins (reviewed by Beato et al., 1995; Karin, 1998; GoÈ ttlicher et al., 1998; Webster and Cidlowski, 1999) .
As to be expected by the GC' wide range of eects and target tissues, genes reportedly regulated by GC have accumulated in a large number. In a survey conducted 1996, a total of 225 GC-regulated genes were listed by Geley et al. (1996a) .
In oncology, GC are an indispensable part of chemotherapy protocols for lymphocytic leukemias and lymphomas. In many of these neoplasias, GC induce apoptosis (Baxter et al., 1971; Harmon et al., 1979; Baxter, 2000) . The glucocorticoid receptor is required for this eect (Baxter et al., 1971; Sibley and Tomkins, 1974) , but events following activation of the receptor are not suciently understood (recently reviewed by Thompson, 1999) . One school of thought proposes a model whereby GC lead to induction of certain genes required for apoptosis (Chapman et al., 1996) . This model has gained credibility since it is consistent with the ®nding that thymocytes of dim/dim mice, whose GR are not able to dimerize and cannot activate classical glucocorticoid-responsive element (GRE)-containing promoters, do not undergo apoptosis in response to GC ). Yet, this requirement for transactivation may be a speci®c requirement for a positive feedback loop, increasing GR numbers per cell: while most cell types downregulate their GR after GC treatment, leukemic T-cells susceptible to GC-induced apoptosis increase their GR numbers via an autoinductive loop (Ramdas et al., 1999) . On the other hand, we have previously shown that stably-transfected GR mutants compromised in transactivating capacity, but normal in transrepressing activity, are as eective in inducing apoptosis as the wild-type receptor, which suggests transrepression as the crucial feature in GC-induced apoptosis, at least in leukemic cells . In this case, the requirement for the autoinductive loop, and therefore transactivation, may be circumvented by generating the necessary amount of GR by overexpression from stably-transfected genes.
While induction of apoptosis from a therapeutic perspective is certainly the most important eect of GC on leukemic cells, other eects may contribute to the usefulness of this class of drugs in chemotherapeutic protocols. To obtain a comprehensive set of data about gene regulation during the early treatment phase of leukemic cells with GC, we used high density probe array technology to assay mRNA levels after 3 h of dexamethasone (dex) treatment in two leukemic T-cell lines, Jurkat and CCRF-CEM C7. For Jurkat cells, we used the two sublines GR-wt (clone A11-1), expressing a stably-transfected rat wildtype receptor, and GR-LS7 (clone F6-1), expressing a mutated receptor with markedly reduced transactivation potential (Godowski et al., 1989; Helmberg et al., 1995) . In cells expressing high levels of GR-wt or GR-LS7, the ®rst apoptotic cells appear after about 16 h of treatment with dex at 10 78 M. Parental Jurkat cells, which lack dex binding activity, go on dividing and do not undergo apoptosis in response to dex.
CCRF-CEM C7 (Foley and Lazarus, 1967; Harmon et al., 1979) cells express an endogenous human GR at a lower level than the stably-transfected Jurkat lines (Geley et al., 1996b) . A full apoptotic response requires a higher dex concentration (10 77 M) and takes longer (48 ± 72 h) to evolve. As the amplitude of regulation after 3 h was quite small in these cells, we obtained a second set of data for a treatment interval of 8 h.
Treatment of cell lines that have been grown in culture for a long time is certainly not directly comparable with therapeutic intervention in human leukemia. Yet, there is no reason to assume that the dierence between primary leukemia cells and long-term cultured cell lines should cause a massive change in the primary target genes of GC in these cells. In addition, Alizadeh et al. (2000) recently demonstrated that expression pro®les of primary leukemic cells did not dier fundamentally from those of cell lines cultured in vitro. Primary isolates typically have the disadvantage of contamination with many dierent cell types. With cultured cell lines, the higher degree of cell homogeneity is a considerable technical advantage in trying to isolate GC-responsive genes. While CEM-C7 cells were cloned some time ago and may since have developed phenotypically diverse subpopulations, the recently subcloned Jurkat lines should be as homogeneous as technically possible. Yet importantly, we also wanted to reduce the eect of cloning artifacts and so expressly designed this study to combine data from three separate sublines. The regulated genes identi®ed in this study suggest mechanisms that may contribute to the therapeutic eect in vivo. In how far these mechanisms actually contribute in the clinical setting will have to be addressed by separate studies.
Results
To evaluate changes in gene expression in T-lymphocytic leukemic cell lines during GC treatment, we determined mRNA expression pro®les in the presence and absence of dex using the Aymetrix Hu6800/ HuGeneFL gene chip system (Lipshutz et al., 1999) . Figure 1 demonstrates a comparison of results obtained by gene chip methodology and Northern transfer analysis for three genes used previously to characterize the Jurkat cell system: glutamine synthase, c-myc and alpha-tubulin  glutamine synthase is not included in Table 1 as it is not suciently regulated in CEM-C7 cells). Results obtained with the two methods correlated well.
To reduce the probability of artifacts resulting from cell line cloning or imperfections inherent to chip technology in¯uencing results, we compared changes in hybridization signal from four dierent sets of experiments: Three-hour treatment periods for the two Jurkat sublines and CEM-C7 cells, and an additional 8-h treatment period for CEM-C7 cells. To identify genes regulated in the same direction in both Jurkat and CEM-C7 cells, we analysed the raw data using the criteria described in`data processing' in the Materials and methods section. Of 5600 genes present on Aymetrix HuGeneFL chips, 98 were singled out as being regulated: 23 were induced and 75 repressed by dex (Tables 1 and 2 ).
In a previous publication , our conclusion that the transrepressive eect of the GR was responsible for induction of apoptosis relied in part on the compromised transactivation potential of the GR-LS7 mutant. To check this impairment in a larger set of genes than possible at that time, we compared relative induction and repression by GR-wt and GR-LS7 in the subpopulations contained in Tables  1 and 2 .`Average induction/repression' has no further biological signi®cance; it is used here only to reevaluate the Jurkat subline system. For induced genes, average induction was by 4.9-fold in Jurkat GR-wt cells and 2.1-fold in GR-LS7 cells (mean of change factors for all induced genes in Table 1 with the exception of the largest and the smallest number to minimize the eect of statistical aberrations). In other words, when estimated by this methodology, transactivation potential of GR-LS7 was still 43% of GR-wt, which is more than we originally determined using other methods . Without repeated measurements in the GR-LS7 line, it is not possible to make de®nitive statements about the degree of induction of an individual gene in this cell line. However, anecdotal observations suggest wide variations between individual genes with respect to the transactivating potential Twenty mg of total RNA were separated on a 1% denaturing agarose gel, transferred to a nylon membrane and analysed by hybridization using probes speci®c for the genes indicated Human pregnancy-specific glycoprotein 13 (PSG13') 3.9 1.2 2.6 2.5
Genes were grouped for the reader's convenience ± assignment to an individual group is, in many cases, debatable
Effects of dex treatment in lymphocytic leukemia P Obexer et al of GR-LS7. For example, induction of glutamine synthase by GR-LS7 was very low (Figure 1 ), as described previously , but induction of IkBa by GR-LS7 (Table 1 ,`MAD-3'), as previously shown by Northern blotting (Heck et al., 1997) was comparable to the degree of induction seen in GR-wt. Of potential importance for this discrepancy, Scheinman et al. (1995) reported no functional GREs in the MAD-3 (IkBa) promoter. Induction of IkB in GR-LS7 cells may, therefore, follow an alternative pathway not aected by the LS7 mutation. For comparison, average change factors for induced genes in CEM-C7 cells were 2.8 after 3 h, 2.6 after 8 h of dex treatment. For repressed genes, average hybridization signal was 62% (equivalent to a change factor of 0.62) compared to untreated cells for Jurkat GR-wt and 58% for GR-LS7. Transrepressive potential was therefore identical for the two GR forms, as reported previously . Average repression for CEM-C7 cells was to 65% after 3 h and further down to 50% after 8 h.
Effects on RNA and protein synthesis
A considerable number of the genes ful®lling the criteria for being`repressed' seemed to have some bearing on the processes of transcription, mRNA splicing and protein synthesis ( Figure 2 and Table 2 ). Figure 1a . Genes marked by an asterisk (*) were repressed only in one of the two cell types and did not therefore ful®ll all criteria to be included in Table 2 . }The ®rst bar for histidyl-tRNAsynthetase was omitted as one data point contained a clearly aberrant value
Oncogene Effects of dex treatment in lymphocytic leukemia P Obexer et al Several proteins that may contribute to the transcription process itself were identi®ed as being repressed: TAFII70-alpha, a basal transcription factor and component of TFIID (Weinzierl et al., 1993) ; the gamma subunit of proximal sequence element-binding transcription factor (PTF), which is required for transcription of small nuclear RNA genes by RNA polymerases II and III (Yoon and Roeder, 1996) ; BAF60b, a subunit of the nucleosome-rearranging SWI/SNF complex (Wang et al., 1996) ; the potential helicase Mi-2 (Seelig et al., 1995) and a RNApolymerase II elongation factor-like protein (genbank Z47087; for pertinent publications see RefSeq NM_003197). In addition, the largest subunit of RNA-polymerase II (Mita et al., 1995; genbank X74874) was repressed only in CEM-C7 cells (therefore not included in Table 2) .
A second group of repressed transcripts consisted of components or suspected components of the splicing machinery, such as hnRNP H (Honore et al., 1995) , a U1 small nuclear ribonucleoprotein 70K-subunit homolog (Elisei et al., 1993) , U1 small nuclear RNPspeci®c C protein (Sillekens et al., 1988) , Survival of Motor Neurons protein (SMN, Chen et al., 1998) , which has been implicated in spliceosomal snRNP biogenesis (Fischer et al., 1997) and arginine-rich nuclear protein (Chaudhary et al., 1991) .
Finally, genes required for protein synthesis were repressed. FKBP-rapamycin-associated protein (FRAP; , although expressed only at low levels, was strongly repressed (less than half the original value) in all three cell lines. FRAP activates translation of many mRNAs by increasing phosphorylation of eukaryotic initiation factor 4E binding protein (4E-BP1) and p70 S6 kinase (p70S6k) (rev. by Brown and Schreiber, 1996) . This translation activation is also necessary for G1 progression. mRNA-levels of two tRNA synthetases, i.e. cysteine and histidine (Cruzen and Ar®n, 1994; Tsui and Siminovitch, 1987) were repressed in both cell types. A third, valyl-tRNA synthetase (X59303; Hsieh and Campbell, 1991) was repressed in Jurkat cells only (not included in Table 2 ). Also repressed was the signal recognition particle receptor, which is required to dock the nascent protein/signal recognition particle complex to the ER membrane (Hortsch et al., 1988) , indicating that GC might adversely aect the synthesis of membrane and/ or secreted proteins.
Both Jurkat and CEM-C7 cells undergo apoptosis in response to GC. Of course, in conjunction with this process, translation and transcription gradually have to come to a halt. For repression of mRNA or protein synthesis to be of importance in its own right, it would have to precede the ®rst signs of apoptosis. Therefore, we undertook a time-resolved analysis of measurable parameters associated with transcription, translation and apoptosis in all three cell lines. Uridine-uptake and methionine-uptake were determined as a proxy for transcription and translation, respectively. Apoptosis was quanti®ed in two ways: First, we determined the percentage of fragmented nuclei by propidium iodide staining of DNA to quantify the`sub-G1 population' by¯ow cytometry. Nuclear fragmentation, however, is thought to be a late-stage phenomenon in the apoptotic process. An event that has been reported to occur early in that process is the breakdown of Genes were grouped for the reader's convenience ± assignment to an individual group is, in many cases, debatable. } In parenthesis as one data point contained a clearly aberrant value mitochondrial transmembrane potential DC (Marchetti et al., 1996; Bortner and Cidlowski, 1999) , which can be measured as a loss of¯uorescence intensity from dyes such as CMXRos, whose uptake into mitochondria is dependent on transmembrane potential. Experimental results are summarized in Figure 3 . In both Jurkat sublines, which have high receptor levels and undergo apoptosis starting at approximately 16 h, GC treatment for 9 ± 12 h represses uptake of uridine and methionine to 60 ± 70% of untreated controls. In contrast, the percentage of cells undergoing apoptosis stays very low for up to 15 h after initiation of treatment. In CEM-C7 cells, for which receptor numbers are lower, the ®rst signs of apoptosis are usually seen after about 36 h. After 24 h, uridineuptake was 84%, methionine-uptake 75% of untreated controls, whereas the percentage of apoptotic cells remained at background levels. Methionine incorporation continued to fall and reached 54% of untreated cells after 36 h when still little signs of apoptosis could be detected. Thus, we conclude that inhibition of transcription and translation is an early eect of GC exposure and not the consequence of the induction of an apoptotic program.
Other effects of potential importance for chemotherapy
Regulation of several genes suggested an explanation of synergism of GC treatment with other chemotherapeutic drugs. One strategy of antineoplastic therapy is to interfere with production of the large amounts of deoxyribonucleotides necessary for DNA replication. To this end, structurally modi®ed nucleotide analogs, so-called antimetabolites, are used, which compete with normal substrate molecules to block nucleotide synthesis pathways (Chabner et al., 1996) . The use of methotrexate, another chemotherapeutic drug, has a similar rationale. It inhibits the synthesis of tetrahydrofolic acid, a cofactor in C1-group transfer necessary at several steps in purine-and pyrimidine synthesis. GC were found to reduce expression of a number of genes required for nucleotide synthesis (Figure 4 ). The gene encoding multifunctional protein CAD, an enzyme catalyzing three successive steps at the start of pyrimidine synthesis (Iwahana et al., 1996) , was repressed, as well as the gene for thymidylate kinase, which adds the second phosphate residue to dTMP (Huang et al., 1994) . Likewise, two enzymes essential for tetrahydrofolic acid synthesis were repressed: 5,10-methenyltetrahydrofolate synthetase (Dayan et al., 1995) and dihydrofolate reductase (Chen et al., 1984) . Alkylating agents are another frequently used class of chemotherapeutic agents. Basically, these agents work by electrophilic attacks on nitrogen and oxygen atoms in macromolecules, notably DNA. Tumor cells have been shown to develop resistance to alkylating agents by increasing intracellular concentrations of glutathione, thereby substituting the sulphur atom of glutathione to intercept the electrophilic attack and reducing the damage to DNA in the process (Chabner et al., 1996) . By repressing a subunit of gamma- Figure 3 Time-dependence of dex eects on uridine-uptake, methionine-uptake and parameters associated with apoptosis. Cells were cultured in the presence or absence of dex for the times indicated. Pulse-labeling with uridine and methionine was performed during the last 3 h of the respective incubation periods. Uptake is expressed for dex-treated cells as a percentage of uptake of vehicle-treated controls, mean+1 standard deviation of triplicates. Percentages of CMX Ros-negative cells and sub-G1-population after propidium-iodide staining were determined bȳ ow cytometry and are shown only for dex-treated cells glutamylcysteine synthetase (Gipp et al., 1995) , an enzyme essential for glutathione synthesis, GC may interfere with this escape mechanism. At the same time, a microsomal glutathione-S-transferase is induced (Table 1) , which may for a while counteract the previous eect, but ultimately lead to more rapid depletion of glutathione.
Effects on the GR and associated proteins
It has been shown that in cells susceptible to GCinduced apoptosis, GC drive an autoinductive feedback loop increasing the number of GR per cell (Eisen et al., 1988; Gomi et al., 1990; Ramdas et al., 1999) . This is in direct contrast to other cell types, where GC have a negative eect on GR expression (Burnstein et al., 1994; Denton et al., 1993) . The positive feedback loop has also been demonstrated in the CEM-C7 cell line used in this study (Antakly et al., 1989; Ashraf et al., 1991) . Our gene chip analysis con®rms this result: GR mRNA level was elevated slightly after 3 h of GC treatment and more than doubled after 8 h ( Figure 5) . In Jurkat cells, human GR mRNA was not detected, which is in good agreement with a lack of dex binding in the parental cells used to generate the cell clones used in this study, which were stably transfected with the rat GR . The oligonucleotide probe set on the gene chip is speci®c for the human mRNA and does not recognize the highly expressed rat GR. Eects of dex on GR expression level. Cells were grown in the presence or absence of dex for the times indicated, RNA was extracted and analysed by microarrays, as detailed in Materials and methods. Bars represent measured mRNA expression levels, rather than ratios as in Figures 1, 2 and 4 . Readings in the shaded area constitute background+noise levels. Note that the Jurkat cell clones do not express the human GR measured by the chip, but instead high levels of stably-transfected rat GR not detected by the chip Oncogene Effects of dex treatment in lymphocytic leukemia P Obexer et al Interestingly, while the GR itself is induced by dex, three genes of the`repressed' list ( Table 2 ) encode proteins that have been found associated with the GR: hsp70 (Tai et al., 1992) , the`immunophilin-like' protein phosphatase 5 (Silverstein et al., 1999 ) and a predominantly nuclear protein known under the names of glucocorticoid receptor-interacting protein (Zeiner and Gehring, 1995) , receptor-associating protein of 46 kDa (RAP46; Zeiner et al., 1997) and hsp70-associated protein 46 (Hap46; Zeiner et al., 1999) . RAP46 has been shown to inhibit GC-induced apoptosis (Kullmann et al., 1998) .
Discussion
We designed an experimental system using three dierent, but similar, cell lines to search for genes concordantly regulated by GC in a setup that mimicks GC treatment of T-lymphoblastic leukemia. This system provides the means to ®lter out noise from false positive (=falsely regulated) results in single-chip experiments, as well as idiosyncrasies pertaining only to individual cell lines re¯ecting developmental stage of the original neoplastic cell or cloning artifacts. In viewing the data of this study, it is important to realize that (1) occasional`bad' data points will occur in all forms of array hybridization experiments, and (2) the calculation of a change factor in a single experiment, by dividing the expression level of a gene in GC-treated cells by that of vehicle-treated cells, will result only in an approximation of the`real' change factor seen, e.g., in a Northern blot. The quality of this approximation is directly related to the expression level of a given gene. For highly-abundant genes, a given level of experimental noise will be of little in¯uence on calculated change factors, but problems arise with low-abundance genes. Obviously, expression signals of low-abundance genes approach the cuto line between expressed/nonexpressed genes. In the Aymetrix system, this cuto usually is between a raw data reading of 30 and 70. If GC treatment, for example, resulted in the mRNA-level of a gene being raised from 50 to 80 with a`noise' of +20, calculated change factors in single experiments might range from 3.3 (100/30) to 0.85 (60/70), while the actual change factor would be 1.6 (80/50). Therefore, it is essential to combine data from several experiments to even out this error.
Taking into account these considerations, the experimental approach chosen here seems to work well to ®lter out genes consistently regulated in the cell lines used, as exempli®ed by the identi®cation of genes for which GC regulation is well established, such as MAD-3 (IkB; Auphan et al., 1995; Scheinman et al., 1995) and c-myc (Thulasi et al., 1993) . However, the procedure clearly does not identify all of those genes. We set data processing criteria to minimize false positives, i.e., genes that ful®ll the prede®ned requirements by chance, thereby necessarily increasing the population of false negatives: genes regulated in both cell types as judged by Northern blotting, but failing to meet the full set of inclusion criteria (data not shown). Due to the possibility of false positives, no conclusions should be based on the appearance of any single gene in Tables 1 and 2 without further veri®cation. Conversely, non-appearance in these tables is without any meaning due to the certainty of a large population of false negatives. Low-abundance genes in particular will escape detection due to varying quality of individual data points. Identifying an increasing percentage of a hypothetical`total' of regulated genes could be achieved only by performing increasing numbers of repetitions of identical experiments with concomitant statistics.
Of the genes induced in Jurkat GR-wt cells, a few individuals are induced to a comparable extent in GR-LS7 cells, which weakens our previous conclusion that GC-induced apoptosis is mediated by the repressive function of the GR. If apoptosis relied on induction of one of those few genes, that hypothetical mechanism would constitute an alternative explanation of the demonstrated fact that GR-LS7 is equally eective in inducing apoptosis as the wild-type GR. However, our interpretation did not solely rely on the GR-LS7 mutant, but equally on cells expressing a second mutant, GR-Ndel, lacking the N-terminal activation domain, and cells expressing retinoic acid receptor alpha that undergo apoptosis in response to retinoic acid. We therefore still believe our previous conclusion to be correct. In addition, we interpret the unexpected ®nding that a subset of the genes induced in GR-wt cells was induced to a comparable extent in GR-LS7 cells as a hint that there may be alternative indirect ways of GC induction that dier from the classical direct GREmediated mechanism.
Using the methodology described provided a distinct repression pattern of genes of established or probable importance for the functions of transcription, mRNA splicing or protein synthesis. Subsequent measurements of uridine and methionine uptake into dex-treated cells suggested a reduction of RNA and protein synthesis to a level of 65% prior to an early sign of apoptosis, the breakdown of mitochondrial transmembrane potential. As the bulk of cellular RNA is ribosomal and transfer RNA, their respective repression would also be expected to eventually aect protein synthesis. Repression of protein synthesis by GC has been shown previously (Helmberg et al., 1990 , Caron-Leslie et al., 1994 , and a comprehensive reduction of transcription, splicing and protein synthesis by GC is in line with anecdotal observations from laboratory work. RNAextractions from GC-treated cells routinely yield slightly lower amounts of RNA than vehicle-treated controls; In addition, presumptively`unregulated' house-keeping genes, such as beta-actin and alphatubulin, seem to be moderately repressed when adjusted to cell count (Hartmann et al., 1999 and A Helmberg, unpublished observations ). Yet these dierences are lost in the usual representation of Northern blots, where`regulated' genes are normalized oǹ unregulated' house keeping genes.
Whether the observed moderate reduction in RNA and protein synthesis contributes to induction of apoptosis, for example by pushing yet-unde®ned proteins essential for cell survival below a critical level, is presently not clear. Cycloheximide, at 10 mg/ml (35 mM), completely blocks protein synthesis and induces apoptosis in Jurkat and CEM cells after a few hours (data not shown). We lowered cycloheximide concentrations until the dynamics of apoptosis induction resembled that of GC-induced apoptosis. At that concentration, 1.4 mg/ml (5 mM), inhibition of methionine-uptake by cycloheximide still was considerably stronger ± to less than 10% of untreated controls (data not shown) ± than inhibition by dex (60 ± 70%). From these observations, we tend to conclude that a general inhibition of protein synthesis would have to be stronger than that eected by dex to induce apoptosis per se. However, that the additive eect of a general reduction in transcription/splicing/protein synthesis and speci®c repression of potential survival genes combine to reach a critical level and induce the apoptotic process cannot be excluded. Repression or absence of several of the genes listed in Table 2 has been reported to promote apoptosis, e.g. for Survival of Motor Neurons (SMN; Schrank et al., 1997) , myeloid cell dierentiation protein (Mcl-1; Altmeyer et al., 1997; Moulding et al., 1998) or receptorassociating protein of 46 kDa (RAP46; Kullmann et al., 1998) .
Although the short period of treatment used in this study should favor identi®cation of direct target genes of GC, incipient cell cycle arrest could still aect arrest-sensitive mRNAs and proteins with short halflives. Using a dierent experimental system, we recently registered a surprisingly small overlap between GC-regulated genes in proliferating cells versus cells arrested in G1/G0 by overexpression of the Cdkinhibitor p16/INK4a, while cells in both conditions were still directed towards apoptosis (Tonko et al., 2001) . Dierences observed between the two studies are in part attributable to an incomplete overlap of gene populations represented on Aymetrix and Incyte arrays, but in part are likely to be due to as yet little-understood dierences in performance between the two types of chip technology.
Apart from induction of apoptosis, regulation of genes identi®ed in this study may contribute to the bene®ts of GC in chemotherapy protocols. A reduction in the rate of protein synthesis may be therapeutically bene®cial in itself by reducing the speed of cell growth. For example, translation initiation co-mediated by FKBP-rapamycin-associated protein has been shown to be necessary for G1 progression (Albers et al., 1993) . In addition to this stand-alone eect of GC, several of the genes found to be regulated may contribute to synergistic eects with other frequentlyused chemotherapeutic agents. Repression of deoxynucleotide synthesis by anti-metabolites and methotrexate is one of the most frequently used approaches in anticancer therapy. Repression of the tetrahydrofolate pathway, as well as thymidylate kinase, by GC is a beautiful example of synergism between the two drug classes on a molecular level. Another such example regarding GC and alkylating agents might be the reduction in expression of a glutathione-forming enzyme, gamma-glutamylcysteine synthetase.
The ability of GC to repress individual genes by several dierent mechanisms has long been recognized. We now suggest that GC coordinately regulate multiple individual genes to achieve a general suppression of macromolecule biosynthesis. It remains to be shown whether GC trigger one speci®c apoptotic pathway, or whether apoptosis is a cell-speci®c response to GCmediated suppression of macromolecule synthesis. This pleiotropic eect might explain the diculty in identifying genes that mediate GC-induced apoptosis, and might explain why the majority of GC-resistant cell lines harbour mutated GRs or express lower-thannormal levels of wild-type GR: It seems unlikely that single gene mutations downstream of the GR can confer GC resistance.
Materials and methods

Cell culture
Cells were cultivated in RPMI 1640 supplemented with 10% fetal bovine serum, 10 mM HEPES, 50 mM beta-mercaptoethanol and containing 100 U/ml Penicillin and 100 mg/ml Streptomycin. Dex treatment was performed at a concentration of 10 78 M in Jurkat cells, 10 77 M in CEM-C7 cells and controls were treated with vehicle (ethanol) for identical periods of time.
Preparation of biotin-labeled cRNA and GeneChip hybridization
Logarithmically growing cells were treated with either dex or the vehicle, 100% ethanol, for three respectively 8 h. Total RNA was extracted by standard procedures, and poly(A) + RNA was enriched by binding to and elution from oligo-dT coupled to magnetic beads (Dynal).
Starting with approximately 1 mg of poly(A) + RNA, cDNA was constructed using the GibcoBRL Superscript choice system and a T7-(T)24 primer to introduce a T7 promoter.
Using approximately 0.5 ± 1 mg cDNA as template, a complex biotin-labeled riboprobe was synthesized with the help of the Ambion T7 Megascript kit and two biotin-labeled nucleotides, Bio-11-CTP and Bio-16-UTP, from ENZO Pharmaceuticals. The 6 h in vitro transcription reaction yielded approximately 70 mg cRNA, of which 20 mg were fragmented and used to hybridize an Aymetrix Hu6800/ HuGeneFL GeneChip.
Chip hybridization, washing and staining with a streptavidin-phycoerythrin conjugate were performed using Aymetrix instrumentation according to the company's recommended protocols.
Data processing
mRNA steady-state levels were expressed as numerical values representing the average dierence of hybridization signals, measured as¯uorescence intensity, between perfect match and central-mismatch oligonucleotide probe sets. A second variable taken into account was the`absent'/'present' call:
Oncogene Effects of dex treatment in lymphocytic leukemia P Obexer et al based on a complex algorithm, Aymetrix software issues aǹ absent' (not expressed) or`present' (expressed) call for each gene measured. Approximately 20% of genes interrogated in each sample were called present. Raw data can be accessed on website www.uibk.ac.at/c/c5/c511/helmberg/genechip_in-dex.html. Data from dierent chips were normalized using the parameter of total chip signal (the sum of all hybridization signals on a chip) and imported into a MS Excel spreadsheet for calculations and logical operations. Ratios between gene-speci®c signals from treated versus untreated cells were calculated.
Data analysis was performed by selecting genes above (for induction) or below (for repression) speci®ed ratios for treated versus untreated cells. For this to make sense, all ratios have to have positive values. Yet,`not expressed' or absent'-readings vary between slightly negative (e.g., 720) and approximately +60. For example, a gene being induced from 50 to 110 ful®lls our primary criterion of a ratio 42. Yet, if it went from 720 to 110, the ratio would be negative and the gene would be unjusti®edly excluded. Therefore, negative values were replaced by +10 for calculations. Each of these replacements was checked carefully to ensure that the replacement of a negative value by a positive one did not distort the result, i.e. lead to arti®cial inclusion or exclusion of the respective gene.
Our goal was to identify transcripts regulated very early during GC treatment of leukemic cells. We therefore attempted to set apart those genes that were concordantly regulated in the two Jurkat and in the CEM-C7 cell lines by combining the change factors from four measurements (eight chips). Looking at an early time point is necessary to be able to distinguish between genuine regulatory eects and consequences of incipient apoptosis. The short duration of treatment implies that breadth of regulation is still relatively small. When applying the generally used criterion of at least twofold induction/repression in all four comparisons, not a single gene made the cut. As this cannot be taken to mean that GC do not regulate genes in leukemic cells, we lowered the stringency of search criteria. The goal of data analysis is to identify the extreme tails of the distribution of deviations from the unchanged state. The cut-o between these tails and the rest is inevitably somewhat arbitrary. Using genes of known glucocorticoid regulation as validation, we empirically arrived at the combination of three ratios, 42, 41.8, 41.5 for`induction ' and 50.5, 50.65, 50.85 for`repression'. So as not to lose a potentially interesting gene by a singlè outlier' among the eight data points per gene, the fourth ratio was not taken into account. While the stringency of these criteria may seem very low, we have several examples of genes narrowly missing to match the full set of criteria while being unequivocally regulated in a Northern blot (data not shown).
To be included in Tables 1 or 2 , a gene had to ful®ll all of the following six criteria: (1) a change factor (ratio of dextreated by vehicle-treated cells) of at least two for induction or lower than 0.5 for repression in at least one of the four treated/untreated comparisons; (2) change factors in the same direction in at least two of the other three comparisons with cutos of 1.8 and 1.5 for induced genes and 0.65 and 0.85 for repressed ones; (3) a mirroring of the regulation in the Jurkat system in the CEM-C7 system and vice versa, meaning a change in the same direction in both cell types. The remaining criteria (4), (5) and (6) share a common rationale: when working with ratios, it is necessary to de®ne minimum expression levels, as statistical noise from non-expressed or borderline-expressed genes will occasionally result in thè right' combination of ratios. To exclude such genes, also the following criteria had to be met: (4) a`present' call by the Aymetrix software in at least one of the eight measurements to exclude non-expressed genes; (5) the`present' call(s) had to coincide with the regulation in question. e.g., if a candidate gene ful®lled the ratio criteria for`upregulation' by GC but had its required`present' call(s) only in untreated cells, the gene was excluded; (6) a minimum`additive' expression level of 100 of the gene in question in the Jurkat and CEM lines, determined by adding up the four measurements of treated cells for induced genes and of untreated cells for repressed genes. This criterion de®nes a¯oor at a mean expression level of 25. While the level chosen can be debated, having such a criterion in place proved important to exclude a large number of borderline-expressed genes, many of which can be expected to have been false positives.
Uptake experiments and quantitation of apoptosis
Uridine and methionine uptake were performed as described (Helmberg et al., 1990) , except for a reduction in pulselabeling time to 3 h and, for determination of methionine uptake, a doubling of [ 3 H]-methionine activity to 2 mCi per well and a ®rst wash using 10% trichloroacetic acid.
Apoptosis was quanti®ed by determining the sub-G1-population of propidium-stained nuclei (Nicoletti et al., 1991) . The status of mitochondrial transmembrane potential DC was assayed by CMXRos staining. CMXRos (Molecular Probes, M-7512; Poot et al., 1996) is readily sequestered by functioning mitochondria, but washes out of the cells once the mitochondrion's membrane potential is lost. 1 ± 5610 5 cells were incubated with CMXRos at a ®nal concentration of 30 ng/ml for 10 min at 378C, washed once in phosphatebuered saline and analysed by¯ow cytometry within a few minutes. Fluorescence was measured in the red region of the optical spectrum.
